Serum Institute of India to start Covishield supply to COVAX countries
"The first consignment from the Pune facility of Serum Institute of India was scheduled to leave for Nepal today. However, due to some reason, it has been delayed by two to three days," said SII sources.
Nov 23, 2021, 08:13 AM IST
SII chairman Cyrus Poonawalla warns against mixing of COVID-19 vaccine, here’s why
"I am against the mixing of two different vaccines. There is no need to mix two different vaccines," said Cyrus Poonawalla.
Aug 14, 2021, 07:06 AM IST
Hope to launch Covovax vaccine for adults in October this year, for kids in 2022 first quarter: SII CEO Adar Poonawalla
Serum Institute of India (SII) CEO said, "The Covovax vaccine for kids will be launched in the first quarter of the next year most likely in January-February."
Aug 06, 2021, 18:52 PM IST
Good news for travellers, says Serum Institute CEO Adar Poonawalla as 16 European countries recognise Covishield
"It is indeed good news for travellers, as we see sixteen European countries recognising Covishield as an acceptable vaccine for entry," tweeted SII CEO Adar Poonawalla.
Jul 18, 2021, 07:09 AM IST
No application received for EU authorisation of Covishield: European Medicines Agency
"For the COVID-19 vaccine Covishield to be evaluated for use in the EU, the developer needs to submit a formal marketing authorisation application to EMA, which to date has not been received," the EMA said at a press briefing.
Jul 17, 2021, 12:37 PM IST
Serum Institute CEO Adar Poonawalla assures help to Indians amid reports of Covishield not qualifying for EU ‘Green Pass’
"I realise that a lot of Indians who have taken COVISHIELD are facing issues with travel to the E.U., I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," said Adar Poonawalla.
Jun 28, 2021, 12:03 PM IST
SII to launch second COVID-19 vaccine Covavax by September: Report
SII plans to introduce Covavax, its second COVID-19 vaccine, in India by September.
Jun 18, 2021, 06:49 AM IST
India aims to procure 20-25 crore COVID-19 vaccine by July end: Report
Amid continuous efforts to accelerate the vaccination process in the country, the Centre on Sunday (May 30, 2021) said that it targets to procure 20-25 crore coronavirus vaccine doses by July-end, and 30 crore doses in August-September.
May 31, 2021, 10:06 AM IST
Centre widened COVID-19 vaccination drive without considering stock, says Serum Institute
The executive director of Serum Institute of India (SII) Suresh Jadhav on Friday alleged that the central government widened the COVID-19 vaccination drive without into account the available stock of vaccines.
May 22, 2021, 07:55 AM IST
'It would take 2-3 years for entire world population to get fully vaccinated,' says SII CEO Adar Poonawalla
Serum Institute of India (SII) CEO Adar Poonawalla stated that "It would take 2-3 years for the entire world population to get fully vaccinated."
May 18, 2021, 23:19 PM IST
Adar Poonawalla exits Panacea Biotec, sells entire stake for Rs 118 crore
As per BSE block deal data, Poonawalla sold 31,57,034 scrips he held in the firm at a price of Rs 373.85 per share.
May 18, 2021, 07:56 AM IST
Hyderabad based Bharat Biotech to start producing coronavirus vaccines in Pune
The Hyderabad-based Bharat Biotech International Ltd will soon start manufacturing Covid-19 vaccines in Pune, through subsidiary Biovet Pvt Ltd, Maharashtra Deputy Chief Minister Ajit Pawar announced.
May 14, 2021, 19:45 PM IST
Bill Gates says COVID vaccine formula should not be shared with India, developing nations, sparks row
Bill Gates has made a controversial statement regarding the patents in vaccine technology and is facing heat from all around
Apr 30, 2021, 12:19 PM IST
India delays big exports of AstraZeneca vaccine as Covid-19 cases surge, say sources
India has put a temporary hold on all major exports of the AstraZeneca coronavirus shot made by the Serum Institute of India (SII), to meet domestic demand as infections rise, two sources told Reuters.
Mar 25, 2021, 06:21 AM IST
Centre asks states, UTs to increase gap between two doses of Covishield
The Centre directed states, UTs to administer the second dose of COVISHIELD at 4-8 weeks’ interval after the first dose.
Mar 22, 2021, 16:40 PM IST
COVID-19: Nepal to begin inoculation drive for elderlies as it receives made-in-India vaccines
Nepal has expedited preparations to start inoculating elderly and most vulnerable age groups from next month as it received a batch of COVID-19 vaccines purchased from India. A batch of one million Covishield vaccines developed by the Serum Institute of India (SII) was delivered on Sunday (February 21) via an Air India flight.
Feb 21, 2021, 23:37 PM IST
DCGI nod to Serum Institute of India for phase 2 and 3 human clinical trials of Oxford vaccine candidate
Currently, phase 2 and 3 clinical trials of the Oxford vaccine candidate is going on in the United Kingdom, phase 3 clinical trial in Brazil and phase 1 and 2 clinical trials in South Africa.
Aug 03, 2020, 07:55 AM IST
